Many Seniors With Nonbacterial Acute URI Prescribed Antibiotics

Share this content:
Many Seniors With Nonbacterial Acute URI Prescribed Antibiotics
Many Seniors With Nonbacterial Acute URI Prescribed Antibiotics

MONDAY, May 15, 2017 (HealthDay News) -- A considerable proportion of elderly patients with a nonbacterial acute upper respiratory tract infection (AURI) are prescribed antibiotics, according to research published online May 9 in the Annals of Internal Medicine.

Michael Silverman, M.D., from St. Joseph's Health Care in London, Canada, and colleagues conducted a retrospective analysis of linked administrative health care data to examine the prevalence of antibiotic prescribing for nonbacterial AURIs in primary care physician practices. Data were included for 8,990 primary care physicians and 185,014 patients aged 66 years or older who presented with a nonbacterial AURI (common cold, acute bronchitis, acute sinusitis, or acute laryngitis [53.4, 31.3, 13.6, and 1.6 percent, respectively]).

The researchers found that 46 percent of the patients received an antibiotic prescription, with 69.9 percent of prescriptions for broad-spectrum agents. The likelihood of receiving prescriptions was increased for mid- and late-career physicians versus early-career physicians (rate difference, 5.1 and 4.6 percent, respectively), physicians trained outside the United States or Canada (3.6 percent), and physicians who saw 25 to 44 or 45 or more versus fewer than 25 patients per day (3.1 and 4.1 percent, respectively).

"In this low-risk elderly cohort, 46 percent of patients with a nonbacterial AURI were prescribed antibiotics," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Cost-Effectiveness of PCSK9 Inhibitors Called Into Question

Cost-Effectiveness of PCSK9 Inhibitors Called Into Question

Researchers say price would have to be between $4,000 and $5,000 per year to be cost-effective

Vitamin B6, B12 Supplements May Up Risk of Lung Cancer in Men

Vitamin B6, B12 Supplements May Up Risk of ...

Increased odds only seemed to affect men or male smokers

Tablet Use Encourages Patients to Explore Diabetes Risk

Tablet Use Encourages Patients to Explore Diabetes Risk

Replacing magazines with tablets can help patients learn about diabetes risk, take preventive action

is free, fast, and customized just for you!

Already a member?

Sign In Now »